MedTrace Logo

Fever Management in Children with Febrile Neutropenia

NCT05189236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-03-05

No results posted yet for this study

Summary

The aim of this study is to determine the effect of the cold steam application on body temperature in combination with the treatment algorithm in fever management in children with febrile neutropenia.

Conditions

Interventions

PROCEDURE

Control Group (Only Algorithm of Febrile Neutropenia Management)

Common Procedure Steps 1. The child is admitted to the unit and evaluated. 2. The objective of the study is explained to the children and children's parents, and their consent is obtained after they have read and signed the informed consent form. 3. The inclusion and exclusion criteria are evaluated. 4. The group of the child to be included in the study is determined in accordance with the randomization order. 5. The first section of the patient information and follow-up form is filled out. 6. The algorithm of Febrile Neutropenia Management is applied. The room temperature is kept constant at 21-24 degrees. Procedure Steps for Control Group: 1. Common procedure steps are followed. 2. The body temperature of the child are recorded in the second section of the Patient Information and Follow-up Form until the fever is kept under control (until the discharge criteria are met, - 72 hours without fever and the culture result is negative).

PROCEDURE

Experimental Group (Algorithm of Febrile Neutropenia Management+Cold Steam)

Procedure Steps for Experiment Group: 1. Common procedure steps are followed. 2. Cold steam is continuously applied until the fever is kept under control (until the discharge criteria are met, - 72 hours without fever and the culture result is negative). 3. The body temperature of the child are recorded in the second section of the Patient Information and Follow-up Form from the time the patient is admitted until the fever is kept under control (until the discharge criteria are met, - 72 hours without fever and the culture result is negative).

Sponsors & Collaborators

  • Acibadem University

    lead OTHER

Principal Investigators

  • Zehra Kan Öntürk, Assist Prof · Acibadem University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-11
Primary Completion
2023-07-04
Completion
2023-07-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05189236 on ClinicalTrials.gov